Every year, viral respiratory infections place a significant burden on the health care system.

The CDC predicts that influenza, respiratory syncytial virus and COVID-19 collectively will account for 27.3 million to 47.7 million outpatient visits, 1.1 million to 2.1 million hospitalizations and 73,000 to 207,000 deaths in the United States between October 2024 and September 2025, with direct and indirect costs in the billions of dollars.

Fortunately, multiple vaccines are available for these infections, as well as monoclonal antibody products (clesrovimab, nirsevimab) which provide infants with passive immunity against RSV. The CDC recommends annual influenza vaccination for all patients aged 6 months or older and a single dose of RSV vaccine for older adults and pregnant women at 32 to 3

See Full Page